• 제목/요약/키워드: Xujun

검색결과 4건 처리시간 0.018초

從《東医宝監》的編撰特点探討許浚的學術思想 (To discuss the Academic Thoughts of Xujun based on the compilation characteristic of Dong-Eui-Bo-Gam)

  • 왕영
    • 한국의사학회지
    • /
    • 제23권2호
    • /
    • pp.43-46
    • /
    • 2010
  • Dong-Eui-Bo-Gam is a general medical literature, writing by Korea physician Xujun, who makes reference of Chinese medical literatures, Taoist literatures, historical records, Confucian literatures and so forth prior Ming Dynasty. It coveres many fields, such as medical theory, etiology, pulse theory, herb, prescription, internal medicine, surgery, gynecology, pediatrics, acupuncture, regimen, YunQi and so forth. Dong-Eui-Bo-Gam combines medical science and many others, using clustering arrangements, fully reflects Xujun's academic thoughts, and his rich clinical experiences.

Information System fur Ship Management

  • Xujun, Xubo
    • 한국항해항만학회:학술대회논문집
    • /
    • 한국항해항만학회 2001년도 Proceeding of KIN-CIN Joint Symposium 2001 on Satellite Navigation/AIS, lntelligence , Computer Based Marine Simulation System and VDR
    • /
    • pp.104-107
    • /
    • 2001
  • Based on the analysis of the functions of ship management company, this paper aims to explore how to build the platform to transmit anti process the information about ships by means of modern information management so as to solve a series of problems caused by blockages in information transmitting in present ship’s management. The paper also talks about the necessity of establishing various resource bases and using different information communicating methods to realize the resource sharing and intellectualization of ship’s business.

  • PDF

Galectin-1 Promotes Gastric Carcinoma Progression and Cisplatin Resistance Through the NRP-1/c-JUN/Wee1 Pathway

  • Zhengyang Pan;Guoxi Xu;Yan Zhang;Meiling Wu;Jiahui Yu;Xujun He;Wei Zhang;Junfeng Hu
    • Journal of Gastric Cancer
    • /
    • 제24권3호
    • /
    • pp.300-315
    • /
    • 2024
  • Purpose: Gastric cancer (GC) is among the deadliest malignancies and the third leading cause of cancer-related deaths worldwide. Galectin-1 (Gal-1) is a primary protein secreted by cancer-associated fibroblasts (CAFs); however, its role and mechanisms of action of Gal-1 in GC remain unclear. In this study, we stimulated GC cells with exogenous human recombinant galectin-1 protein (rhGal-1) to investigate its effects on the proliferation, migration, and resistance to cisplatin. Materials and Methods: We used simulated rhGal-1 protein as a paracrine factor produced by CAFs to induce GC cells and investigated its promotional effects and mechanisms in GC progression and cisplatin resistance. Immunohistochemical (IHC) assay confirmed that Gal-1 expression was associated with clinicopathological parameters and correlated with the expression of neuropilin-1 (NRP-1), c-JUN, and Wee1. Results: Our study reveals Gal-1 expression was significantly associated with poor outcomes. Gal-1 boosts the proliferation and metastasis of GC cells by activating the NRP-1/C-JUN/Wee1 pathway. Gal-1 notably increases GC cell resistance to cisplatin The NRP-1 inhibitor, EG00229, effectively counteracts these effects. Conclusions: These findings revealed a potential mechanism by which Gal-1 promotes GC growth and contributes to chemoresistance, offering new therapeutic targets for the treatment of GC.

Advantages of Restoring miR-205-3p Expression for Better Prognosis of Gastric Cancer via Prevention of Epithelial-mesenchymal Transition

  • Zhang, Zhen;He, Xujun;Xu, Ji;Zhang, Genhua;Yang, Yue;Ma, Jie;Sun, Yuanshui;Ni, Haibin;Wang, Fengyong
    • Journal of Gastric Cancer
    • /
    • 제20권2호
    • /
    • pp.212-224
    • /
    • 2020
  • Purpose: miR-205 is a tumor suppressor and plays an important role in tumor invasiveness. However, the role of miR-205 in human gastric cancer (GC) epithelial-mesenchymal transition (EMT) remains unclear. The aim of this study was to investigate the molecular mechanism of miR-205 in the regulation of EMT in GC invasion. Materials and Methods: Quantitative polymerase chain reaction (qPCR) was used to detect the expression of miR-205 in GC. Further, the correlation between the pathological parameters and prognosis of GC was statistically analyzed. A transwell model was used to evaluate the effect of miR-205-3p on the invasion and migration of GC cells. qPCR, western blotting, and luciferase assay were performed to analyze the relationship and target effects between miR-205-3p and the expression of zinc finger electron box binding homologous box 1 (ZEB1) and 2 (ZEB2). Results: We found that the levels of miR-205-3p were significantly lower (P<0.05) in GC tissues than in matched normal tissues. Additionally, the expression of miR-205-3p was related to the tumor invasion depth, lymph node metastasis, lymph node invasion, and tumor, node, metastasis stage. Patients with lower miR-205-3p expression levels in the tumors had a poorer prognosis. The in vitro assays indicated that miR-205-3p could affect the invasion ability and EMT of GC cells by targeting the expression of both ZEB1 and ZEB2. Conclusions: miR-205-3p promotes GC progression and affects the prognosis of patients by targeting both ZEB1 and ZEB2 to directly influence EMT.